A computer program developed by GNS Healthcare could be used to model and predict disease progression and response to treatment in people with multiple myeloma. Called “Gemini, the in silico ” Patient” (“in silico” refers to analyses done using computer simulation), the program was built through a collaboration between multiple biopharmaceutical companies, academic medical centers, and the Multiple Myeloma Research Foundation (MMRF). Gemini builds on data from the CoMMpass Study, a project from the MMRF that…
You must be logged in to read/download the full post.
The post GNS Healthcare Launches Computer Model of Disease Progression, Treatment Responses in Myeloma appeared first on BioNewsFeeds.